Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00921297 · ClinicalTrials.gov registry record · NA

Cataract Removal and Alzheimer's Disease

A NA study, sponsored by University Hospitals Cleveland Medical Center.

Completed
Registry status
NA
Development phase
122
Enrollment target

NCT00921297 is a NA study that has completed, run by University Hospitals Cleveland Medical Center. The registered enrollment target is 122 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00921297, a NA study, has completed, sponsored by University Hospitals Cleveland Medical Center.

COMPLETED
Registry status
NA
Development phase
122 participants
Enrollment target

Study Summary

Two very common aging-related diseases in older adults are Alzheimer's disease (AD) and cataracts. In elderly adults, these two diseases frequently occur in the same person. Although a cure for AD is currently unavailable, cataracts can be effectively treated with surgery in most people. The removal of cataracts has documented benefits for visual performance and for reducing accidents and falls. However, it has been the experience of the ophthalmologists, and others in the field, that patients, caregivers, and primary care doctors are reluctant to proceed with cataract surgery once an individual is given the diagnosis of AD. It is thought that cataract surgery will not improve the AD patient's quality of life, vision, and cognition. The investigators have designed this study to determine whether or not this is true.

Interventions

  • PROCEDURE Immediate Cataract Surgery

Trial Details

FieldValue
Enrollment Target 122 participants
Start Date 2009-06
Est. Completion 2017-03-30
Phase NA

What the Registry Record Tells You About NCT00921297

The ClinicalTrials.gov registry entry for NCT00921297 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 122 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University Hospitals Cleveland Medical Center, which has 230 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Immediate Cataract Surgery is the first listed.

NCT00921297 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00921297 about?

NCT00921297 is a clinical study titled "Cataract Removal and Alzheimer's Disease". Two very common aging-related diseases in older adults are Alzheimer's disease (AD) and cataracts. In elderly adults, these two diseases frequently occur in the same person. Although a cure for AD is currently unavailable, cataracts can be effectively treated with surgery in most people. The removal...

What is the current status of trial NCT00921297?

This trial is currently completed. It is a NA study. The enrollment target is 122 participants. The study started on 2009-06. Estimated completion is 2017-03-30.

What interventions are being tested in trial NCT00921297?

The interventions under investigation include: Immediate Cataract Surgery (PROCEDURE).

Who is sponsoring clinical trial NCT00921297?

This trial is sponsored by University Hospitals Cleveland Medical Center, which has 230 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.